Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000518810 | SCV000614179 | uncertain significance | not specified | 2017-06-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000641379 | SCV000763020 | benign | Nemaline myopathy 2 | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000641379 | SCV001455501 | uncertain significance | Nemaline myopathy 2 | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome |
RCV001535536 | SCV001749510 | not provided | Nebulin-related early-onset distal myopathy | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 03-06-2019 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. |